Before lithium became available to treat this potentially devastating illness, bipolar I sufferers experienced repeated ...

Net product sales of CAPLYTA were $680.5 million for the full year 2024. This represents an increase of 47% compared to 2023.

BD affects millions but remains misunderstood, underdiagnosed, and underfunded. Researchers are working to change this by ...

A machine learning model trained on electronic health record (EHR) data predicted progression to schizophrenia or bipolar ...

It's well-known that smartwatches can track anything from sleep and stress to respiratory rate and exercise. However, a ...

Biohaven's NDA for Troriluzole was accepted by the FDA, potentially leading to approval in Q3 2025. Click here to find out ...

Patients with mood disorders experience recurrences of depressive and manic episodes throughout their lives. In this regard, ...

His UTI was treated with the appropriate antibiotics and a fluid-intake increase. He was diagnosed with alcohol dependence and dementia as well as bipolar disorder, manic phase.

This phase is characterized by emotional "lows ... It's important to treat mania and bipolar disorder. A person might be a danger to themself during a manic episode. Risky behaviors can lead ...

Tokyo, Japan and Cambridge, UK, 14 February 2025 – Nxera Pharma Co., Ltd. (“Nxera” or “the Company”; TSE 4565) provides an update on operational activities and reports its consolidated results for the ...

SSRIs are a focus of a new Trump executive order that installs Robert F. Kennedy Jr.'s 'Make America Healthy Again' commission. Here's what they do.